Resumé

Objectives: To examine sex differences in prevalent comorbidity and frailty across age and European regions. Methods: This is a cross-sectional study based on 113,299 Europeans aged 50+ participating in the Survey of Health, Ageing and Retirement in Europe from 2004–2005 to 2015. Sex differences in the Comorbidity Index and the Frailty Phenotype were investigated using ordinal logistic regressions. Results: European women had generally higher odds of prevalent comorbidity (OR 1.11, 95% CI 1.07–1.15) and frailty (OR 1.56, 95% CI 1.51–1.62). Sex differences increased with advancing age. No overall sex difference in comorbidity was found in Western Europe, but women had more comorbidity than men in Eastern (OR 1.30, 95% CI 1.18–1.44), Southern (OR 1.23, 95% CI 1.15–1.30), and Northern (OR 1.08, 95% CI 1.01–1.16) Europe. Women were frailer than men in all regions, with the largest sex difference in Southern Europe (OR 1.84, 95% CI 1.72–1.96). Conclusions: European women are frailer and have slightly more comorbidity than European men lending support for the male–female health survival paradox.

OriginalsprogEngelsk
TidsskriftInternational Journal of Public Health
Vol/bind64
Udgave nummer7
Sider (fra-til)1025-1036
ISSN1661-8556
DOI
StatusUdgivet - sep. 2019

Fingeraftryk

Sex Characteristics
Comorbidity
Retirement
Health Surveys
Cross-Sectional Studies
Logistic Models
Health

Emneord

  • Comorbidity
  • Europe
  • Frailty
  • SHARE
  • Sex differences

Citer dette

@article{2019639e78a045a49ebfd16582a57ecc,
title = "Sex Differences in Comorbidity and Frailty in Europe",
abstract = "Objectives: To examine sex differences in prevalent comorbidity and frailty across age and European regions. Methods: This is a cross-sectional study based on 113,299 Europeans aged 50+ participating in the Survey of Health, Ageing and Retirement in Europe from 2004–2005 to 2015. Sex differences in the Comorbidity Index and the Frailty Phenotype were investigated using ordinal logistic regressions. Results: European women had generally higher odds of prevalent comorbidity (OR 1.11, 95{\%} CI 1.07–1.15) and frailty (OR 1.56, 95{\%} CI 1.51–1.62). Sex differences increased with advancing age. No overall sex difference in comorbidity was found in Western Europe, but women had more comorbidity than men in Eastern (OR 1.30, 95{\%} CI 1.18–1.44), Southern (OR 1.23, 95{\%} CI 1.15–1.30), and Northern (OR 1.08, 95{\%} CI 1.01–1.16) Europe. Women were frailer than men in all regions, with the largest sex difference in Southern Europe (OR 1.84, 95{\%} CI 1.72–1.96). Conclusions: European women are frailer and have slightly more comorbidity than European men lending support for the male–female health survival paradox.",
keywords = "Comorbidity, Europe, Frailty, SHARE, Sex differences, Comorbidity, Europe, Frailty, Sex differences, SHARE",
author = "Ahrenfeldt, {Linda Juel} and S{\"o}ren M{\"o}ller and Mikael Thinggaard and Kaare Christensen and Rune Lindahl-Jacobsen",
year = "2019",
month = "9",
doi = "10.1007/s00038-019-01270-9",
language = "English",
volume = "64",
pages = "1025--1036",
journal = "International Journal of Public Health",
issn = "1661-8556",
publisher = "Springer",
number = "7",

}

Sex Differences in Comorbidity and Frailty in Europe. / Ahrenfeldt, Linda Juel; Möller, Sören; Thinggaard, Mikael; Christensen, Kaare; Lindahl-Jacobsen, Rune.

I: International Journal of Public Health, Bind 64, Nr. 7, 09.2019, s. 1025-1036.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Sex Differences in Comorbidity and Frailty in Europe

AU - Ahrenfeldt, Linda Juel

AU - Möller, Sören

AU - Thinggaard, Mikael

AU - Christensen, Kaare

AU - Lindahl-Jacobsen, Rune

PY - 2019/9

Y1 - 2019/9

N2 - Objectives: To examine sex differences in prevalent comorbidity and frailty across age and European regions. Methods: This is a cross-sectional study based on 113,299 Europeans aged 50+ participating in the Survey of Health, Ageing and Retirement in Europe from 2004–2005 to 2015. Sex differences in the Comorbidity Index and the Frailty Phenotype were investigated using ordinal logistic regressions. Results: European women had generally higher odds of prevalent comorbidity (OR 1.11, 95% CI 1.07–1.15) and frailty (OR 1.56, 95% CI 1.51–1.62). Sex differences increased with advancing age. No overall sex difference in comorbidity was found in Western Europe, but women had more comorbidity than men in Eastern (OR 1.30, 95% CI 1.18–1.44), Southern (OR 1.23, 95% CI 1.15–1.30), and Northern (OR 1.08, 95% CI 1.01–1.16) Europe. Women were frailer than men in all regions, with the largest sex difference in Southern Europe (OR 1.84, 95% CI 1.72–1.96). Conclusions: European women are frailer and have slightly more comorbidity than European men lending support for the male–female health survival paradox.

AB - Objectives: To examine sex differences in prevalent comorbidity and frailty across age and European regions. Methods: This is a cross-sectional study based on 113,299 Europeans aged 50+ participating in the Survey of Health, Ageing and Retirement in Europe from 2004–2005 to 2015. Sex differences in the Comorbidity Index and the Frailty Phenotype were investigated using ordinal logistic regressions. Results: European women had generally higher odds of prevalent comorbidity (OR 1.11, 95% CI 1.07–1.15) and frailty (OR 1.56, 95% CI 1.51–1.62). Sex differences increased with advancing age. No overall sex difference in comorbidity was found in Western Europe, but women had more comorbidity than men in Eastern (OR 1.30, 95% CI 1.18–1.44), Southern (OR 1.23, 95% CI 1.15–1.30), and Northern (OR 1.08, 95% CI 1.01–1.16) Europe. Women were frailer than men in all regions, with the largest sex difference in Southern Europe (OR 1.84, 95% CI 1.72–1.96). Conclusions: European women are frailer and have slightly more comorbidity than European men lending support for the male–female health survival paradox.

KW - Comorbidity

KW - Europe

KW - Frailty

KW - SHARE

KW - Sex differences

KW - Comorbidity

KW - Europe

KW - Frailty

KW - Sex differences

KW - SHARE

U2 - 10.1007/s00038-019-01270-9

DO - 10.1007/s00038-019-01270-9

M3 - Journal article

C2 - 31236603

VL - 64

SP - 1025

EP - 1036

JO - International Journal of Public Health

JF - International Journal of Public Health

SN - 1661-8556

IS - 7

ER -